VRTX Bull Call Spread Strategy

VRTX (Vertex Pharmaceuticals Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductance regulator gene. Additionally, they provide TRIKAFTA for individuals with CF aged six years and older who possess at least one F508del mutation. Beyond its established CF therapies, Vertex maintains a robust and diverse clinical pipeline. This includes VX-864, currently in Phase 2 for alpha-1 antitrypsin (AAT) deficiency; VX-147, also in Phase 2, addressing APOL1-mediated focal segmental glomerulosclerosis (FSGS) and other serious kidney conditions; VX-880, a potential treatment for Type 1 Diabetes undergoing Phase 1/2 trials; VX-548, a NaV1.8 inhibitor in Phase 2 for various forms of acute, neuropathic, and musculoskeletal pain; and CTX001, which is in Phase 3 development for severe sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). The company distributes its pharmaceutical products through specialty pharmacies and distributors across the United States, while international sales are facilitated via a network of specialty distributors, retail chains, hospitals, and clinics.

VRTX (Vertex Pharmaceuticals Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $133.43B, a trailing P/E of 30.30, a beta of 0.31 versus the broader market, a 52-week range of 374.17-546.17, average daily share volume of 1.4M, a public-listing history dating back to 1991, approximately 6K full-time employees. These structural characteristics shape how VRTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.31 indicates VRTX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a bull call spread on VRTX?

A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.

VRTX snapshot

As of August 14, 2026, spot at $504.94, ATM IV 24.51%, IV rank 8.71%, expected move 7.03%. The bull call spread on VRTX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this bull call spread structure on VRTX specifically: VRTX IV at 24.51% is on the cheap side of its 1-year range, which favors premium-buying structures like a VRTX bull call spread, with a market-implied 1-standard-deviation move of approximately 7.03% (roughly $35.48 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VRTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on VRTX should anchor to the underlying notional of $504.94 per share and to the trader's directional view on VRTX stock.

VRTX bull call spread setup

The VRTX bull call spread below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VRTX at $504.94 on that close, the first option leg uses a $505.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VRTX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VRTX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$505.00$14.50
Sell 1Call$530.00$4.45

VRTX bull call spread risk and reward

Net Premium / Debit
-$1,005.00
Max Profit (per contract)
$1,495.00
Max Loss (per contract)
-$1,005.00
Breakeven(s)
$515.05
Risk / Reward Ratio
1.488

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.

VRTX bull call spread payoff curve

Modeled P&L at expiration across a range of underlying prices for the bull call spread on VRTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

VRTX bull call spread profit and loss curve at expiration with breakevens and current spot markedVRTX bull call spread payoff at expiration-$1000-$500$0$500$1000$200$400$600$800$1000Underlying Price ($)P&L at Expiration ($)BE $515.05Spot $504.94
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%-$1,005.00
$111.65-77.9%-$1,005.00
$223.30-55.8%-$1,005.00
$334.94-33.7%-$1,005.00
$446.59-11.6%-$1,005.00
$558.23+10.6%+$1,495.00
$669.87+32.7%+$1,495.00
$781.52+54.8%+$1,495.00
$893.16+76.9%+$1,495.00
$1,004.81+99.0%+$1,495.00

When traders use bull call spread on VRTX

Bull call spreads on VRTX reduce the cost of a bullish VRTX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.

VRTX thesis for this bull call spread

The market-implied 1-standard-deviation range for VRTX extends from approximately $469.46 on the downside to $540.42 on the upside. A VRTX bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on VRTX, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current VRTX IV rank near 8.71% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VRTX at 24.51%. As a Healthcare name, VRTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VRTX-specific events.

VRTX bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VRTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VRTX alongside the broader basket even when VRTX-specific fundamentals are unchanged. Long-premium structures like a bull call spread on VRTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current VRTX chain quotes before placing a trade.

Frequently asked questions

What is a bull call spread on VRTX?
A bull call spread on VRTX is the bull call spread strategy applied to VRTX (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With VRTX stock at $504.94 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed VRTX chain strike and the premiums come straight from that session's bid/ask midpoint.
How are VRTX bull call spread max profit and max loss calculated?
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the VRTX bull call spread priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 24.51%), the computed maximum profit is $1,495.00 per contract and the computed maximum loss is -$1,005.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VRTX bull call spread?
The breakeven for the VRTX bull call spread priced on this page is roughly $515.05 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The VRTX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a bull call spread on VRTX?
Bull call spreads on VRTX reduce the cost of a bullish VRTX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
How does current VRTX implied volatility affect this bull call spread?
VRTX ATM IV is at 24.51% with IV rank near 8.71%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related VRTX analysis